Trial Profile
Effectiveness of on-demand therapy using 20-mg vonoprozan for patients with mild reflux esophagitis well controlled with a proton pump inhibitor (PPI)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Oct 2018
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Reflux oesophagitis
- Focus Therapeutic Use
- 04 May 2017 New trial record